Theravance BioPharma (TBPH.US) Stock Community - Hot Topic Discussions

Event Tracking

Nov20

Theravance Biopharma to Hold Virtual Investor Event to Discuss Ampreloxetine as Potential Therapy

16:00

Nov11

Theravance BioPharma released FY2025 Q3 earnings on November 10 After-Market EST, actual revenue USD 19.99 M (forecast USD 19.89 M), actual EPS USD 0.07 (forecast USD -0.1283)

00:00

Theravance BioPharma released FY2025 9 Months Earnings on November 10 After-Market (EST), actual revenue USD 61.57 M, actual EPS USD 0.8768

00:00

Nov10

Theravance Biopharma Reports Q3 Earnings and Reviews Strategies to Enhance Shareholder Value

21:09

Nov4

Theravance Biopharma to Release Q3 2025 Earnings on November 10

13:52

Nov3

Theravance BioPharma to Release FY2025 Q3 Earnings on November 10 After-Market EST, Forecast Revenue USD 19.89 M, EPS USD -0.1283

00:13

Schedules & Filings

Schedules

Filings

Nov10

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 19.99 M, Net Income 3.615 M, EPS 0.07

Aug12

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 26.2 M, Net Income 54.84 M, EPS 1.08

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 15.39 M, Net Income -13.58 M, EPS -0.2731

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change